Are you Dr. Nixon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1250 E Marshall St
# Internal
Richmond, VA 23298Phone+1 804-828-6163Fax+1 804-828-4926
Summary
- Dr. Daniel Nixon, DO is an infectious disease specialist in Richmond, Virginia. He is currently licensed to practice medicine in Virginia and Ohio. He is affiliated with VCU Medical Center and is an Associate Professor at Virginia Commonwealth University.
Education & Training
- Virginia Commonwealth University Health SystemFellowship, Infectious Disease, 1993 - 1996
- OhioHealth/Doctors HospitalResidency, Internal Medicine, 1990 - 1993
- Ohio University Heritage College of Osteopathic Medicine in AthensClass of 1990
Certifications & Licensure
- VA State License 1993 - 2024
- OH State License 1992 - 1994
- AOA Board of Internal Medicine Infectious Disease
- AOA Board of Internal Medicine Internal Medicine
Clinical Trials
- Consent for Use of Stored Patient Specimens for Future Testing Start of enrollment: 2002 Feb 13
- Respiratory Virus Hospitalization Study (FLU 003 Plus) Start of enrollment: 2009 Aug 01
- Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 48 citationsHCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.Jasmohan S. Bajaj, Richard K. Sterling, Naga S. Betrapally, Daniel E. Nixon, Michael Fuchs
Alimentary Pharmacology & Therapeutics. 2016-07-15 - 24 citationsHuman Immunodeficiency Virus–Experienced Clinician Workforce Capacity: Urban–Rural Disparities in the Southern United StatesRose S Bono, Bassam Dahman, Lindsay M. Sabik, Lauren Yerkes, Yangyang Deng
Clinical Infectious Diseases. 2021-05-04 - 32 citationsPulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of Ant...Ken M. Kunisaki, Dennis E. Niewoehner, Gary Collins, Daniel E. Nixon, Ellen Tedaldi
HIV Medicine. 2015-04-01
Press Mentions
- People in the News, April 20April 20th, 2021
Grant Support
- Phase III Study Of Subcutaneous Recombinant IL-2 In Patients W/ HIV-1 InfectionNational Center For Research Resources2005–2006
- Richmond AIDS Consortium 'Cpcra'National Institute Of Allergy And Infectious Diseases2004–2006
- Herpesvirus Genomic CleavageNational Institute Of Allergy And Infectious Diseases1997–2001
Professional Memberships
- Member